Isatuximab - Sanofi
At a glance
- Drug Originator ImmunoGen
- Drug Licenced by Sanofi
- Drug Class Antibodies; Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; CD38 antigen inhibitors; Natural killer cell stimulants; T lymphocyte stimulants
- USA Patent Applicants SANOFI AVENTIS US
- USA Patents 9
- BLAs 1
- International Patents 175
Disclaimer